These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37591705)

  • 1. Development and validation of capillary electrophoresis sodium dodecyl sulfate (CE-SDS) method for purity analysis of pertussis toxin, filamentous haemagglutinin and pertactin antigens.
    Thorat S; Ogale P; Gautam M; Shaligram U; Gairola S
    Vaccine; 2023 Sep; 41(40):5854-5862. PubMed ID: 37591705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a spectrophotometric method for quantification of residual cyclodextrin (DIMEB; Heptakis) in pertussis antigens.
    Shinde B; Patil D; Nandre V; Gautam M; Doshi P; Gairola S
    Biologicals; 2023 Feb; 81():101663. PubMed ID: 36791626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interlaboratory method validation of capillary electrophoresis sodium dodecyl sulfate (CE-SDS) methodology for analysis of mAbs.
    Li M; Yu C; Wang W; Wu G; Wang L
    Electrophoresis; 2021 Oct; 42(19):1900-1913. PubMed ID: 34240427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and implementation of standardized method for detecting immunogenicity of acellular pertussis vaccines in Korea.
    Park C; Huh DH; Han SB; Choi GS; Kang KR; Kim JA; Kang JH
    Clin Exp Vaccine Res; 2019 Jan; 8(1):35-42. PubMed ID: 30775349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single radial immunodiffusion as a method for the assay of the acellular pertussis vaccine components, pertussis toxoid, filamentous haemagglutinin and pertactin.
    Xing DK; Canthaboo C; Corbel MJ; Schild GC
    Biologicals; 1998 Sep; 26(3):217-24. PubMed ID: 10208723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.
    Morgeaux S; Chagnaud P; Variot P; Le Tallec D; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2020; 2020():161-202. PubMed ID: 32788038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of USP antibody standard for system suitability in capillary electrophoresis sodium dodecyl sulfate (CE-SDS) for release and stability methods.
    Esterman AL; Katiyar A; Krishnamurthy G
    J Pharm Biomed Anal; 2016 Sep; 128():447-454. PubMed ID: 27344634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
    Buasri W; Impoolsup A; Boonchird C; Luengchaichawange A; Prompiboon P; Petre J; Panbangred W
    BMC Microbiol; 2012 Apr; 12():61. PubMed ID: 22524455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of pertactin IgG antibodies for the diagnosis of pertussis.
    Trollfors B; Lagergård T; Gunnarsson E; Taranger J
    Clin Microbiol Infect; 2003 Jul; 9(7):585-9. PubMed ID: 12925096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines.
    Boros CA; Hanlon M; Gold MS; Roberton DM
    Vaccine; 2001 May; 19(25-26):3537-42. PubMed ID: 11348721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and reactogenicity of the component acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous haemagglutinin.
    Kimura M; Kuno-Sakai H; Kamiya H; Ueda K; Isomura S; Koike M; Kato T; Ozaki T; Hirose M; Egami T
    Acta Paediatr Jpn; 1995 Oct; 37(5):562-74. PubMed ID: 8533580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of co-purified acellular pertussis vaccines.
    Xu Y; Tan Y; Asokanathan C; Zhang S; Xing D; Wang J
    Hum Vaccin Immunother; 2015; 11(2):421-7. PubMed ID: 25610957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acellular pertussis vaccine given by accelerated schedule: response of preterm infants.
    Slack MH; Schapira D; Thwaites RJ; Schapira C; Bamber J; Burrage M; Southern J; Andrews N; Miller E
    Arch Dis Child Fetal Neonatal Ed; 2004 Jan; 89(1):F57-60. PubMed ID: 14711858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of Bordetella pertussis toxin and filamentous haemagglutinin concentrations by hydroxyapatite high-performance liquid chromatography.
    Chong P; Jackson G; Cwyk W; Klein M
    J Chromatogr; 1990 Jul; 512():227-36. PubMed ID: 2172264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
    Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative study on a Guinea pig serological method for the assay of acellular pertussis vaccines.
    Winsnes R; Sesardic D; Daas A; Terao E; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):27-40. PubMed ID: 20144450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary Electrophoresis-Sodium Dodecyl Sulfate with Laser-Induced Fluorescence Detection as a Highly Sensitive and Quality Control-Friendly Method for Monitoring Adeno-Associated Virus Capsid Protein Purity.
    Zhang Z; Park J; Barrett H; Dooley S; Davies C; Verhagen MF
    Hum Gene Ther; 2021 Jun; 32(11-12):628-637. PubMed ID: 33081515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories.
    Wong KH; Skelton SK
    J Clin Microbiol; 1989 Dec; 27(12):2805-10. PubMed ID: 2556434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of Bordetella pertussis in BALB/c Mice.
    Bakhshaei P; Kazemi MH; Golara M; Abdolmaleki S; Khosravi-Eghbal R; Khoshnoodi J; Judaki MA; Salimi V; Douraghi M; Jeddi-Tehrani M; Shokri F
    J Interferon Cytokine Res; 2018 Apr; 38(4):161-170. PubMed ID: 29638208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.